Leveraging Managed Care to Increase Access to BCMA-Directed Treatment and Equitable Care in Multiple Myeloma

This activity was originally broadcast in conjunction with the 2023 AMCP Annual Meeting.

Program Description

B-cell maturation antigen (BCMA) has emerged as a therapeutic target in multiple myeloma (MM) as patients with overexpression and activation of BCMA are at risk of disease progression. Drugs targeting BCMA have demonstrated promise in relapsed/refractory disease, even in patients with limited treatment options. As there are various mechanisms of action and modalities for currently available BCMA-targeted agents, pharmacists need to discern the nuances of each agent and differentiate between available therapies to ensure appropriate selection of an agent based on specific patient- and disease-related factors. This program will examine the economic burden of MM and will delve into approaches managed care pharmacists can use to facilitate pathways and ensure cost-effective care. The discussion will also address factors contributing to disparities in MM and the role of managed care professionals in ensuring equitable and timely access to emerging treatments.

Target audience: Managed care and oncology pharmacists

Type of activity: Application
Release date: April 7, 2023
Expiration date: April 7, 2024

Time to complete activity: 1.5 hours

Learner level: Intermediate
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Explore the therapeutic landscape and the patient- and disease-specific factors that drive treatment decisions for the use of BCMA-directed therapies in multiple myeloma (MM).
• Examine the recent clinical updates and guideline-recommended use of BCMA-targeted therapies for MM.
• Investigate best practices in managed care to provide equitable access to BCMA-directed therapies in MM.
• Apply recent updates for BCMA-targeted treatments when developing eligibility criteria and making formulary decisions.

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEU) under the ACPE universal activity number 0290-0000-23-127-H01-P. The activity is available for CE credit through April 7, 2024.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Sara Moran Smith, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose:

• Speaker’s Bureau: Karyopharm
• Consultant: G1 Therapeutics

The following contributors have no relevant financial relationships with commercial interests to disclose:

Faculty

Joseph Kalis, PharmD, BCOP

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Amy H. Seung, PharmD, BCOP, FHOPA, CHCP; Evelina Kolychev, PharmD, BCOP; Kylie Ferrentino; Susan Pordon; Brianna Winters; and Chloe Taccetta

Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms